Compare INUV & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INUV | NMTC |
|---|---|---|
| Founded | N/A | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.8M | 45.5M |
| IPO Year | N/A | N/A |
| Metric | INUV | NMTC |
|---|---|---|
| Price | $3.04 | $0.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $14.00 | $2.23 |
| AVG Volume (30 Days) | 229.6K | ★ 376.6K |
| Earning Date | 02-26-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $98,139,861.00 | $12,097,692.00 |
| Revenue This Year | $20.86 | N/A |
| Revenue Next Year | $14.59 | $32.08 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 25.11 | ★ 250.35 |
| 52 Week Low | $2.34 | $0.40 |
| 52 Week High | $6.27 | $1.39 |
| Indicator | INUV | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 54.31 | 55.70 |
| Support Level | $2.74 | $0.86 |
| Resistance Level | $3.80 | $0.94 |
| Average True Range (ATR) | 0.26 | 0.08 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 41.26 | 43.55 |
Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.